Regeneron
Tarrytown · Founded 1988
About Regeneron
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products to treat serious medical conditions. The company has therapeutic candidates in clinical trials for potentially treating cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
Company Facts
- Founded: 1988
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 10,001+
- Estimated revenue: $10M+
- Total funding: $15.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2024)
- Ticker: nasdaq:REGN
- Website: regeneron.com
- Phone: +118557343648
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/regeneron-95997 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.